塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/09/29 | 6,677 | 6,714 | 6,638 | 6,686 | -3 | ±0% | 1,996,500 |
2023/09/28 | 6,646 | 6,726 | 6,631 | 6,689 | -63 | -0.9% | 1,242,300 |
2023/09/27 | 6,672 | 6,752 | 6,628 | 6,752 | +88 | +1.3% | 1,281,000 |
2023/09/26 | 6,723 | 6,726 | 6,662 | 6,664 | -62 | -0.9% | 771,400 |
2023/09/25 | 6,647 | 6,730 | 6,608 | 6,726 | +121 | +1.8% | 911,200 |
2023/09/22 | 6,589 | 6,645 | 6,578 | 6,605 | -59 | -0.9% | 966,600 |
2023/09/21 | 6,741 | 6,747 | 6,639 | 6,664 | -77 | -1.1% | 1,006,200 |
2023/09/20 | 6,771 | 6,827 | 6,726 | 6,741 | -3 | ±0% | 1,503,400 |
2023/09/19 | 6,706 | 6,786 | 6,696 | 6,744 | -2 | ±0% | 1,348,000 |
2023/09/15 | 6,680 | 6,768 | 6,656 | 6,746 | +92 | +1.4% | 1,673,700 |
2023/09/14 | 6,635 | 6,673 | 6,607 | 6,654 | +46 | +0.7% | 1,018,100 |
2023/09/13 | 6,640 | 6,657 | 6,596 | 6,608 | -37 | -0.6% | 1,049,700 |
2023/09/12 | 6,505 | 6,645 | 6,496 | 6,645 | +159 | +2.5% | 1,755,200 |
2023/09/11 | 6,479 | 6,502 | 6,448 | 6,486 | +23 | +0.4% | 1,012,100 |
2023/09/08 | 6,420 | 6,484 | 6,419 | 6,463 | +44 | +0.7% | 1,596,000 |
2023/09/07 | 6,452 | 6,479 | 6,400 | 6,419 | -33 | -0.5% | 1,081,800 |
2023/09/06 | 6,446 | 6,464 | 6,433 | 6,452 | -12 | -0.2% | 809,000 |
2023/09/05 | 6,429 | 6,464 | 6,411 | 6,464 | +34 | +0.5% | 904,300 |
2023/09/04 | 6,430 | 6,431 | 6,405 | 6,430 | -2 | ±0% | 691,300 |
2023/09/01 | 6,393 | 6,448 | 6,385 | 6,432 | +15 | +0.2% | 833,100 |
2023/08/31 | 6,463 | 6,472 | 6,393 | 6,417 | -74 | -1.1% | 1,890,100 |
2023/08/30 | 6,476 | 6,521 | 6,470 | 6,491 | +14 | +0.2% | 1,023,100 |
2023/08/29 | 6,452 | 6,489 | 6,441 | 6,477 | +53 | +0.8% | 1,089,900 |
2023/08/28 | 6,410 | 6,443 | 6,403 | 6,424 | +66 | +1% | 1,079,700 |
2023/08/25 | 6,323 | 6,372 | 6,307 | 6,358 | +2 | ±0% | 1,089,100 |
2023/08/24 | 6,296 | 6,356 | 6,296 | 6,356 | +28 | +0.4% | 695,200 |
2023/08/23 | 6,324 | 6,355 | 6,310 | 6,328 | -7 | -0.1% | 826,300 |
2023/08/22 | 6,315 | 6,373 | 6,297 | 6,335 | +35 | +0.6% | 1,220,200 |
2023/08/21 | 6,265 | 6,316 | 6,258 | 6,300 | +58 | +0.9% | 859,500 |
2023/08/18 | 6,250 | 6,257 | 6,215 | 6,242 | -14 | -0.2% | 826,500 |
2023/08/17 | 6,272 | 6,286 | 6,240 | 6,256 | -43 | -0.7% | 957,400 |
2023/08/16 | 6,265 | 6,326 | 6,253 | 6,299 | -10 | -0.2% | 1,160,400 |
2023/08/15 | 6,242 | 6,309 | 6,212 | 6,309 | +67 | +1.1% | 984,200 |
2023/08/14 | 6,268 | 6,344 | 6,241 | 6,242 | -13 | -0.2% | 1,317,000 |
2023/08/10 | 6,200 | 6,260 | 6,177 | 6,255 | +55 | +0.9% | 1,536,000 |
2023/08/09 | 6,160 | 6,201 | 6,157 | 6,200 | +47 | +0.8% | 1,187,600 |
2023/08/08 | 6,130 | 6,153 | 6,099 | 6,153 | +51 | +0.8% | 1,012,200 |
2023/08/07 | 6,003 | 6,103 | 5,999 | 6,102 | +88 | +1.5% | 935,800 |
2023/08/04 | 6,003 | 6,028 | 5,986 | 6,014 | -17 | -0.3% | 1,047,100 |
2023/08/03 | 6,099 | 6,121 | 5,993 | 6,031 | -123 | -2% | 1,406,600 |
2023/08/02 | 6,107 | 6,167 | 6,065 | 6,154 | +16 | +0.3% | 2,507,000 |
2023/08/01 | 6,032 | 6,139 | 6,005 | 6,138 | +206 | +3.5% | 3,008,700 |
2023/07/31 | 5,968 | 5,996 | 5,912 | 5,932 | +36 | +0.6% | 1,741,000 |
2023/07/28 | 5,859 | 5,909 | 5,811 | 5,896 | -26 | -0.4% | 1,627,100 |
2023/07/27 | 5,931 | 5,944 | 5,886 | 5,922 | +4 | +0.1% | 791,300 |
2023/07/26 | 5,899 | 5,921 | 5,863 | 5,918 | +38 | +0.6% | 735,700 |
2023/07/25 | 5,949 | 5,949 | 5,871 | 5,880 | -46 | -0.8% | 987,300 |
2023/07/24 | 5,945 | 5,953 | 5,902 | 5,926 | +44 | +0.7% | 666,800 |
2023/07/21 | 5,879 | 5,929 | 5,859 | 5,882 | +40 | +0.7% | 1,133,800 |
2023/07/20 | 5,900 | 5,913 | 5,834 | 5,842 | -52 | -0.9% | 1,078,800 |
401~
450
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 233,900円 | +20.9% | +10.6% | 2.82% | 11.06倍 | 1.46倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 665,000円 | +2.2% | +10.2% | 1.80% | 12.77倍 | 1.28倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 139,300円 | +0.9% | +380.2% | 5.60% | 19.18倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
協和キリン | 220,200円 | -3.5% | -11.3% | 2.72% | 20.23倍 | 1.36倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
エーザイ | 387,800円 | +0.1% | -3.4% | 4.13% | 26.36倍 | 1.30倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム